Enterococci, particularly vancomycin-resistant isolates tend to affect the most vulnerable and immunocompromised patients and are one of the most difficult bacteria to treat. In absence of robust clinical data, we will discuss therapeutic approaches for these recalcitrant organisms
Guests
• Kerry L. LaPlante, PharmD. Professor and Chair, Pharmacy Practice, University of Rhode Island, Kingston, RI.
• William R. Miller, MD. Assistant Professor of Medicine, Division of Infectious Diseases. University of Texas Health science Center at Houston.
Subscribe to the podcast at [ Ссылка ]
Visit [ Ссылка ] to browse issues and/or submit a manuscript.
👍 Subscribe to ASM's YouTube channel at [ Ссылка ]
🔬 Learn more about the American Society for Microbiology at [ Ссылка ]
✅ Become a member today at [ Ссылка ]
📱 Join us on social:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
